Detalhe da pesquisa
1.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
J Eur Acad Dermatol Venereol
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456584
2.
Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
J Eur Acad Dermatol Venereol
; 34(7): 1609-1616, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080907
3.
Sidestream Dark Field (SDF) imaging of oral microcirculation in the assessment of systemic sclerosis.
Microvasc Res
; 126: 103890, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271765
4.
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
Scand J Rheumatol
; 47(1): 62-70, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28990485
5.
The critical need for patient-reported outcome measures to assess the severity and impact of systemic sclerosis.
Br J Dermatol
; 186(1): 11-12, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726765
6.
The molecular pathogenesis of morphoea: from genetics to future treatment targets.
Br J Dermatol
; 177(1): 34-46, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553363
7.
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.
J Eur Acad Dermatol Venereol
; 31(10): 1581-1594, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28786499
8.
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
J Eur Acad Dermatol Venereol
; 31(9): 1401-1424, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792092
9.
The patient knows best: a new self-reported outcome measure for systemic sclerosis.
Br J Dermatol
; 183(4): 610, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253751
10.
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets.
J Eur Acad Dermatol Venereol
; 34(5): e236-e238, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945216
11.
Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.
Ann Rheum Dis
; 73(1): 56-61, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24067785
12.
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.
Arthritis Rheum
; 64(10): 3420-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22328195
13.
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.
Arthritis Rheum
; 64(1): 264-71, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21905008
14.
Biomarkers for skin involvement and fibrotic activity in scleroderma.
J Eur Acad Dermatol Venereol
; 26(3): 267-76, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21819452
15.
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression.
Eur Respir J
; 38(1): 184-90, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21030449
16.
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis.
Arthritis Rheum
; 62(7): 2101-8, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20506355
17.
The psychological impact of facial changes in scleroderma.
Psychol Health Med
; 16(3): 304-12, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21491338
18.
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.
Clin Rheumatol
; 39(1): 27-36, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31111363
19.
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis.
Eur Respir J
; 34(6): 1376-82, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19541722
20.
Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
Ann Rheum Dis
; 68(6): 856-62, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18625615